The British United Provident Association Limited:企業の戦略・SWOT・財務分析

◆英語タイトル:The British United Provident Association Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3721
◆発行会社(調査会社):MarketLine
◆発行日:2019年12月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

The British United Provident Association Limited – Strategy, SWOT and Corporate Finance Report
Summary

The British United Provident Association Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

The British United Provident Association Limited (Bupa) is a health and care services provider. The company funds for the healthcare of its customers through different funding models like insurance. It also provides primary care clinics, hospitals, dental centers and service centers aged people. Bupa delivers its services by partnering with other health providers, associates and distributors with a focus on community development. It has operations spanned across different geographic regions including, the UK, Australia, New Zealand, Spain, Hong Kong, China, India, Thailand, Poland, Brazil, Saudi Arabia and the US among others. It is headquartered in London, UK.

Scope

- Detailed information on The British United Provident Association Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting The British United Provident Association Limited in the form of a SWOT analysis
- An in-depth view of the business model of The British United Provident Association Limited including a breakdown and examination of key business segments
- Intelligence on The British United Provident Association Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about The British United Provident Association Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of The British United Provident Association Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess The British United Provident Association Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on The British United Provident Association Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
The British United Provident Association Limited : Company Overview
The British United Provident Association Limited : Overview and Key Facts
The British United Provident Association Limited : Overview
The British United Provident Association Limited : Key Facts
The British United Provident Association Limited : Key Employees
The British United Provident Association Limited : Key Employee Biographies
The British United Provident Association Limited : Major Products and Services
The British United Provident Association Limited : Company History
The British United Provident Association Limited : Management Statement
The British United Provident Association Limited : Locations and Subsidiaries
The British United Provident Association Limited : Key Competitors
The British United Provident Association Limited : Company Analysis
The British United Provident Association Limited : Business Description
The British United Provident Association Limited : SWOT Analysis
The British United Provident Association Limited : SWOT Overview
The British United Provident Association Limited : Strengths
The British United Provident Association Limited : Weaknesses
The British United Provident Association Limited : Opportunities
The British United Provident Association Limited : Threats
The British United Provident Association Limited : Corporate Financial Deals Activity
The British United Provident Association Limited : Financial Deals Overview
The British United Provident Association Limited : Targets and Partners
The British United Provident Association Limited : Top Deals 2015 – 2019YTD*
The British United Provident Association Limited : Advisors
The British United Provident Association Limited : Top Legal Advisors
The British United Provident Association Limited : Top Financial Advisors
The British United Provident Association Limited : Mergers and Acquisitions
The British United Provident Association Limited : Divestments
The British United Provident Association Limited : Recent Developments
The British United Provident Association Limited : News and Events Summary
The British United Provident Association Limited : Business Expansion
The British United Provident Association Limited : Business Reorganization
The British United Provident Association Limited : Contracts
The British United Provident Association Limited : Corporate Governance
The British United Provident Association Limited : Financial Deals
The British United Provident Association Limited : Financial Performance
The British United Provident Association Limited : Red Flags/Distress Signals
The British United Provident Association Limited : Red Flags/DistressSignals
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: The British United Provident Association Limited : Key Facts
Table 2: The British United Provident Association Limited : Key Employees
Table 3: The British United Provident Association Limited : Company History
Table 4: The British United Provident Association Limited : Locations and Subsidiaries
Table 5: The British United Provident Association Limited : Key Competitors
Table 6: The British United Provident Association Limited : Deal Activity by Deal Type - Volume (TTM*)
Table 7: The British United Provident Association Limited : Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: The British United Provident Association Limited : M&A Average Deal Size - Value (US$m)
Table 9: The British United Provident Association Limited : Targets and Partners
Table 10: The British United Provident Association Limited : Top Deals 2015 - 2019YTD*
Table 11: The British United Provident Association Limited : Legal Advisor Ranking by Value (US$m)
Table 12: The British United Provident Association Limited : Financial Advisor Ranking by Value (US$m)
Table 13: The British United Provident Association Limited : M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: The British United Provident Association Limited : M&A Activity by Geography (2015 - YTD*2019)
Table 15: The British United Provident Association Limited : Divestments Volume and Value Trend (2015 - YTD*2019)
Table 16: The British United Provident Association Limited : Divestments by Geography (2015 - YTD*2019)
Table 17: The British United Provident Association Limited : News and Events Summary
Table 18: The British United Provident Association Limited : Business Expansion
Table 19: The British United Provident Association Limited : Business Reorganization
Table 20: The British United Provident Association Limited : Contracts
Table 21: The British United Provident Association Limited : Corporate Governance
Table 22: The British United Provident Association Limited : Financial Deals
Table 23: The British United Provident Association Limited : Financial Performance
Table 24: The British United Provident Association Limited : Red Flags/Distress Signals
Table 25: The British United Provident Association Limited : Red Flags/DistressSignals

★海外企業調査レポート[The British United Provident Association Limited:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pathway Genomics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Pathway Genomics Corp (Pathway Genomics) is a healthcare laboratory that offers genetic testing services. Its tests comprise liquid biopsy cancer intercept, true hereditary cancer genetic tests, DNA insight general health and wellness genetic tests, DNA insight pharmacogenomics tests, and ca …
  • Ryanair Holdings plc:戦略・SWOT・企業財務分析
    Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Kerecis ehf:製薬・医療:M&Aディール及び事業提携情報
    Summary Kerecis ehf (Kerecis) is a medical device company that provides products that treats chronic wounds and damaged tissue. The company’s flagship product includes Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic …
  • JBS S.A.:戦略・SWOT・企業財務分析
    JBS S.A. - Strategy, SWOT and Corporate Finance Report Summary JBS S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Vestas Wind Systems AS (VWS):企業の財務・戦略的SWOT分析
    Vestas Wind Systems AS (VWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Daiichi Sankyo Co Ltd (4568):医療機器:M&Aディール及び事業提携情報
    Summary Daiichi Sankyo Company Ltd (Daiichi Sankyo) is a holding company that carries out the research, development, manufacture, and marketing of pharmaceutical products. The company offers a wide range of prescription drugs, over-the-counter (OTC) drugs, vaccines, and others. Its portfolio encompa …
  • Transgene Biotek Ltd (526139):企業の財務・戦略的SWOT分析
    Summary Transgene Biotek Ltd (Transgene) is a biotechnology company that develops and commercializes biogeneric drugs, vaccines and biotech products. The company develops products in the areas of oncology, auto-immunity, drug delivery and bio generics. Its products include TBL-0404, TBL-0905, TBL -0 …
  • Hess Corp (HES):企業の財務・戦略的SWOT分析
    Hess Corp (HES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Changmao Biochemical Engineering Co., Ltd:企業の戦略・SWOT・財務分析
    Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • GH Armor Systems Inc.:企業の戦略・SWOT・財務情報
    GH Armor Systems Inc. - Strategy, SWOT and Corporate Finance Report Summary GH Armor Systems Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • XERIS Pharmaceuticals Inc (XERS):製薬・医療:M&Aディール及び事業提携情報
    Summary XERIS Pharmaceuticals Inc (XERIS) is a specialty pharmaceutical company that develops and commercializes injectable and infusible drug formulations. The company’s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous and intramuscular delivery of ultra concentr …
  • Hellenic Petroleum SA (ELPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Hellenic Petroleum S.A. (Hellenic Petroleum) is an integrated oil and gas company. It refines, supplies, and trades oil products, natural gas; and markets fuels in Greece and South-eastern European markets with a network of petrol stations. The company owns and operates vertically integrated …
  • Safety-Kleen Inc:企業の戦略的SWOT分析
    Safety-Kleen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Histogenics Corp (HSGX):企業の財務・戦略的SWOT分析
    Summary Histogenics Corp (Histogenics) is a regenerative medicine company that develops, markets and commercializes products for musculoskeletal disorders. The company provides product such as neocart, a tissue implant produced using a patient’s own cartilage cells which are harvested from non-weigh …
  • Valneva SE:企業のM&A・事業提携・投資動向
    Valneva SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Valneva SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • GNI Group Ltd (2160):企業の財務・戦略的SWOT分析
    Summary GNI Group Ltd (GNI) is a healthcare service provider that researches, develops, manufactures and markets pharmaceutical drugs. The company’s business operations consist of drug discovery activities such as drug discovery research, drug discovery infrastructure, fundamental drug discovery and …
  • Stellar Biotechnologies Inc (SBOT):製薬・医療:M&Aディール及び事業提携情報
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • HeartWare International Inc:企業の戦略的SWOT分析
    HeartWare International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Hochschild Mining plc:企業の戦略・SWOT・財務情報
    Hochschild Mining plc - Strategy, SWOT and Corporate Finance Report Summary Hochschild Mining plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Accelya Kale Solutions Limited (ACCELYA):企業の財務・戦略的SWOT分析
    Accelya Kale Solutions Limited (ACCELYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆